260 related articles for article (PubMed ID: 11679436)
1. Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation.
Pratipanawatr W; Pratipanawatr T; Cusi K; Berria R; Adams JM; Jenkinson CP; Maezono K; DeFronzo RA; Mandarino LJ
Diabetes; 2001 Nov; 50(11):2572-8. PubMed ID: 11679436
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
Miyazaki Y; He H; Mandarino LJ; DeFronzo RA
Diabetes; 2003 Aug; 52(8):1943-50. PubMed ID: 12882909
[TBL] [Abstract][Full Text] [Related]
3. Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].
Storgaard H; Song XM; Jensen CB; Madsbad S; Björnholm M; Vaag A; Zierath JR
Diabetes; 2001 Dec; 50(12):2770-8. PubMed ID: 11723060
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
[TBL] [Abstract][Full Text] [Related]
5. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
6. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients.
Krook A; Björnholm M; Galuska D; Jiang XJ; Fahlman R; Myers MG; Wallberg-Henriksson H; Zierath JR
Diabetes; 2000 Feb; 49(2):284-92. PubMed ID: 10868945
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats.
Ogihara T; Asano T; Ando K; Chiba Y; Sekine N; Sakoda H; Anai M; Onishi Y; Fujishiro M; Ono H; Shojima N; Inukai K; Fukushima Y; Kikuchi M; Fujita T
Diabetes; 2001 Mar; 50(3):573-83. PubMed ID: 11246877
[TBL] [Abstract][Full Text] [Related]
8. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB
Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
[TBL] [Abstract][Full Text] [Related]
9. Reversal of insulin resistance postpartum is linked to enhanced skeletal muscle insulin signaling.
Kirwan JP; Varastehpour A; Jing M; Presley L; Shao J; Friedman JE; Catalano PM
J Clin Endocrinol Metab; 2004 Sep; 89(9):4678-84. PubMed ID: 15356080
[TBL] [Abstract][Full Text] [Related]
10. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action.
Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Mandarino LJ
J Appl Physiol (1985); 2003 Dec; 95(6):2519-29. PubMed ID: 12909611
[TBL] [Abstract][Full Text] [Related]
11. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
12. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
Kim YB; Kotani K; Ciaraldi TP; Henry RR; Kahn BB
Diabetes; 2003 Aug; 52(8):1935-42. PubMed ID: 12882908
[TBL] [Abstract][Full Text] [Related]
13. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.
Morino K; Petersen KF; Dufour S; Befroy D; Frattini J; Shatzkes N; Neschen S; White MF; Bilz S; Sono S; Pypaert M; Shulman GI
J Clin Invest; 2005 Dec; 115(12):3587-93. PubMed ID: 16284649
[TBL] [Abstract][Full Text] [Related]
14. Elevated fasting insulin concentrations associate with impaired insulin signaling in skeletal muscle of healthy subjects independent of obesity.
Korsheninnikova E; Seppälä-Lindroos A; Vehkavaara S; Goto T; Virkamäki A
Diabetes Metab Res Rev; 2002; 18(3):209-16. PubMed ID: 12112939
[TBL] [Abstract][Full Text] [Related]
15. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.
Goodyear LJ; Giorgino F; Sherman LA; Carey J; Smith RJ; Dohm GL
J Clin Invest; 1995 May; 95(5):2195-204. PubMed ID: 7537758
[TBL] [Abstract][Full Text] [Related]
17. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects.
Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Kashyap S; Mandarino LJ
Metabolism; 2004 Sep; 53(9):1233-42. PubMed ID: 15334390
[TBL] [Abstract][Full Text] [Related]
18. Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats.
Giorgino F; Logoluso F; Davalli AM; Napoli R; Laviola L; Hirshman MF; Horton ES; Weir GC; Smith RJ
Diabetes; 1999 Apr; 48(4):801-12. PubMed ID: 10102697
[TBL] [Abstract][Full Text] [Related]
19. Insulin signaling in human skeletal muscle: time course and effect of exercise.
Wojtaszewski JF; Hansen BF; Kiens B; Richter EA
Diabetes; 1997 Nov; 46(11):1775-81. PubMed ID: 9356025
[TBL] [Abstract][Full Text] [Related]
20. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
Vaag A; Lehtovirta M; Thye-Rönn P; Groop L;
Diabet Med; 2001 Jul; 18(7):533-40. PubMed ID: 11553181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
